What is the price-to-earnings ratio of Brainsway?
The price-earnings ratio of Brainsway is currently 1.54.
Brainsway P/E 2025
Brainsway P/E
1.54
Ticker
BWAY.TA
ISIN
IL0011007189
WKN
A0NDVW
As of Aug 8, 2025, Brainsway's P/E ratio was 1.54, a -72.89% change from the 5.68 P/E ratio recorded in the previous year.
The Brainsway P/E history
Brainsway Aktienanalyse
What does Brainsway do?
Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Brainsway's P/E Ratio
The Price to Earnings (P/E) Ratio of Brainsway is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Brainsway's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Brainsway is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Brainsway’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Brainsway stock
How has the price-earnings ratio of Brainsway changed compared to last year?
The price-to-earnings ratio of Brainsway has increased by -72.89% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Brainsway high compared to other companies?
Yes, the price-to-earnings ratio of Brainsway is high compared to other companies.
How does an increase in the price-earnings ratio of Brainsway affect the company?
An increase in the price-earnings ratio of Brainsway would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Brainsway affect the company?
A decrease in the price-earnings ratio of Brainsway would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Brainsway?
Some factors that influence the price-earnings ratio of Brainsway are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Brainsway pay?
Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.
What is the dividend yield of Brainsway?
The current dividend yield of Brainsway is .
When does Brainsway pay dividends?
Brainsway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Brainsway?
Brainsway paid dividends every year for the past 0 years.
What is the dividend of Brainsway?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Brainsway located?
Brainsway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Brainsway from 8/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/8/2025.
When did Brainsway pay the last dividend?
The last dividend was paid out on 8/8/2025.
What was the dividend of Brainsway in the year 2024?
In the year 2024, Brainsway distributed 0 USD as dividends.
In which currency does Brainsway pay out the dividend?
The dividends of Brainsway are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Brainsway
Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
